Washington Trust’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-22
Closed -$784 967
2023
Q1
$784 Hold
22
﹤0.01% 907
2022
Q4
$807 Buy
22
+1
+5% +$40 ﹤0.01% 920
2022
Q3
$1K Sell
21
-1
-5% -$65 ﹤0.01% 917
2022
Q2
$2K Sell
22
-5
-19% -$366 ﹤0.01% 828
2022
Q1
$2K Buy
27
+9
+50% +$761 ﹤0.01% 861
2021
Q4
$2K Buy
+18
New +$1.73K ﹤0.01% 870

Other funds holding SYNH

Washington Trust's SYNH Position: Q2 2023 in Review

Washington Trust sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 22 shares — an estimated $784 sold.

Washington Trust first reported a position in SYNH in Q4 2021 and held it in 6 quarters. The position peaked at $2K in Q2 2022. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Washington Trust reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Washington Trust sold 22 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $784.
  • Washington Trust first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
  • Washington Trust's Syneos Health, Inc. Class A Common Stock position peaked at $2K in Q2 2022.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Washington Trust's 13F filing for Q2 2023, filed 27 Jul 2023.